Savings potential of generic drugs in millions of Euros (effective sales, sales at lowest price, possible savings, savings accumulated). Classification: years, Germany, active phamaceutical ingredient

Shown values refer to:
Year: 2013

Information
Active agentSavings potential
Effective
sales in
Mio. Euro Info		Sales at
lowest
price in
Mio. Euro Info		Possible
savings
in Mio.
Euro		Savings
accumulated
in Mio.
Euro
collapseSum of these 20 agents3,099.22,327.0772.2      
Candesartan 120.962.957.9204.4
Candesartan und Hydrochlorothiazid92.456.935.5563.2
Citalopram (E)82.860.322.5666.1
Clopidogrel98.555.443.1453.7
Ibuprofen259.9238.621.2731.6
Latanoprost 51.228.722.5688.6
Levetiracetam 143.970.873.1146.5
Memantine84.063.021.0752.6
Metoprolol246.6227.019.6772.2
Montelukast45.323.521.8710.4
Olanzapin Info80.244.136.2527.7
Omeprazol210.0182.127.9591.1
Pantoprazole431.8358.473.473.4
Pramipexol 114.088.026.0643.6
Quetiapin 190.6133.956.7261.1
Salmeterol und Fluticason 242.7193.848.9365.6
Simvastatin (E)274.4218.855.6316.7
Tacrolimus142.7116.126.6617.6
Valsartan 99.454.445.0410.6
Valsartan und Hydrochlorothiazid 87.850.037.8491.5
Table was compiled on 19. Apr 2024 18:37 under www.gbe-bund.de
(See also more information on Source(s)/Contact, Comment(s), Links, Refresh period of data)  To the interactive graphics

Table shows following page dimension(s)New selection:
DimensionCurrent dimension valueList of dimension values
Year2013
Change dimension:DimensionRowColumnPage
Year Variable can not be changed
Savings potential
Active agent
The table has 84 cells (21 rows and 4 columns).  
Value selection

Show value selection

  (On the page "Value selection" you can choose for every dimension any dimension value for your selection.)
Interactive graphics    

Source(s)/Contact

Definition(s)

Comment(s)

  • The calculation of the lowest prices includes only indisputed preparations with adequate market coverage.

    • Refresh period of data

    Links

    The Federal Health Monitoring System 19. Apr 2024